Barclays PLC Idexx Laboratories Inc Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Barclays PLC holds 324,861 shares of IDXX stock, worth $161 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

324,861

Previous 307,556 5.63%

Holding current value

$161 Million

Previous $171 Million 2.75%

% of portfolio

0.06%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$515.08 - $576.87 $8.91 Million - $9.98 Million	17,305 Added 5.63%	324,861 $175 Million
Q4 2023 Feb 15, 2024	BUY	$391.37 - $557.56 $23.1 Million - $32.9 Million	59,080 Added 23.78%	307,556 $171 Million
Q3 2023 Nov 07, 2023	BUY	$432.42 - $556.67 $34.2 Million - $44 Million	79,102 Added 46.7%	248,476 $109 Million
Q2 2023 Aug 03, 2023	BUY	$450.7 - $503.61 $37.3 Million - $41.7 Million	82,862 Added 95.78%	169,374 $85.1 Million
Q1 2023 May 04, 2023	SELL	$406.01 - $514.59 $12 Million - $15.2 Million	-29,612 Reduced 25.5%	86,512 $43.3 Million

Q4 2022 Feb 13, 2023	BUY	$324.64 - $441.27 $8.29 Million - $11.3 Million	25,527 Added 28.18%	116,124 $47.4 Million
Q3 2022 Nov 03, 2022	SELL	$325.8 - $407.78 $2.11 Million - $2.64 Million	-6,475 Reduced 6.67%	90,597 $29.5 Million
Q2 2022 Aug 12, 2022	SELL	$327.37 - $553.44 $12.1 Million - $20.5 Million	-37,041 Reduced 27.62%	97,072 $34 Million
Q1 2022 May 16, 2022	SELL	$466.52 - $631.01 $18.3 Million - $24.8 Million	-39,272 Reduced 22.65%	134,113 $73.4 Million
Q4 2021 Feb 14, 2022	BUY	$586.54 - $666.48 $7.14 Million - $8.12 Million	12,176 Added 7.55%	173,385 $114 Million
Q3 2021 Nov 09, 2021	BUY	$621.9 - $705.76 $13.8 Million - $15.6 Million	22,128 Added 15.91%	161,209 $100 Million
Q2 2021 Aug 13, 2021	BUY	$486.36 - $637.08 $1.75 Million - $2.3 Million	3,606 Added 2.66%	139,081 $87.8 Million
Q1 2021 May 13, 2021	BUY	$465.18 - $551.79 $1.93 Million - $2.29 Million	4,146 Added 3.16%	135,475 $66.3 Million
Q4 2020 Feb 11, 2021	BUY	$383.85 - $499.87 $8.92 Million - $11.6 Million	23,238 Added 21.5%	131,329 $65.6 Million
Q3 2020 Nov 12, 2020	SELL	$334.54 - $406.31 $3.49 Million - $4.24 Million	-10,444 Reduced 8.81%	108,091 $42.5 Million
Q2 2020 Aug 12, 2020	SELL	$230.66 - $330.16 $6.1 Million - $8.73 Million	-26,431 Reduced 18.23%	118,535 $39.1 Million
Q1 2020 May 13, 2020	SELL	$182.94 - $290.97 $4.87 Million - $7.75 Million	-26,620 Reduced 15.51%	144,966 $35.1 Million
Q4 2019 Feb 10, 2020	BUY	$248.66 - $285.01 $3.67 Million - $4.21 Million	14,771 Added 9.42%	171,586 $44.8 Million
Q3 2019 Nov 14, 2019	BUY	$260.07 - $289.93 $5.79 Million - $6.46 Million	22,272 Added 16.55%	156,815 $42.6 Million
Q2 2019 Aug 14, 2019	SELL	$215.53 - $275.33 $2.43 Million - $3.1 Million	-11,276 Reduced 7.73%	134,543 $37 Million
Q1 2019 May 15, 2019	BUY	$178.02 - $225.69 $2.24 Million - $2.84 Million	12,581 Added 9.44%	145,819 $32.6 Million
Q4 2018 Feb 14, 2019	SELL	$176.18 - $248.92 $6.59 Million - $9.31 Million	-37,413 Reduced 21.92%	133,238 $24.8 Million
Q3 2018 Nov 14, 2018	BUY	$218.82 - $254.46 $14.7 Million - $17 Million	66,962 Added 64.58%	170,651 $42.6 Million
Q2 2018 Aug 14, 2018	SELL	$185.56 - $227.9 $4.99 Million - $6.13 Million	-26,898 Reduced 20.6%	103,689 $22.6 Million
Q1 2018 May 15, 2018	BUY	$157.81 - $204.73 $2.6 Million - $3.37 Million	16,448 Added 14.41%	130,587 $25 Million
Q4 2017 Feb 14, 2018	BUY	$147.68 - $168.37 $7.2 Million - $8.21 Million	48,773 Added 74.62%	114,139 $17.8 Million
Q3 2017 Nov 14, 2017	BUY	$150.32 - $166.46 $9.83 Million - $10.9 Million	65,366	65,366 $10.2 Million

Others Institutions Holding IDXX

# of Institutions

1,213

Shares Held

71.7M

Call Options Held

168K

Put Options Held

394K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $41.4B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account